-
-
-
-
-
-
-
Petros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Corporate Update
-
-
-
-
-
-
-
(Ignore, company said this press release was fake) Petros Pharmaceuticals (PTPI) to be Acquired by Henry Crown and Company for $3.25 per share
-
-
-
-
-
-
-
Petros Pharmaceuticals (PTPI) Announces Positive Results of OTC Label Comprehension Study for Erectile Dysfunction Drug STENDRA
-
-
-
-
-
-
-
Petros Pharmaceuticals, Inc (PTPI) Announces $7.5 Million Offering of of Common Stock, Warrants
-
-
-
-
-
-
-
Petros Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Petros Pharmaceuticals Announces $5.7 Million Registered Direct Offering
-
-
-
-
-
-
-
Petros Pharmaceuticals Welcomes Dr. Mohit Khera to Steering Committee to Expand into Non-Rx Status for Stendra® (avanafil)
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

